TRIACORT Drug Patent Profile
Which patents cover Triacort, and what generic alternatives are available?
Triacort is a drug marketed by Solvay and is included in one NDA.
The generic ingredient in TRIACORT is triamcinolone acetonide. There is one drug master file entry for this compound. Eighty suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Triacort
A generic version of TRIACORT was approved as triamcinolone acetonide by SUN PHARMA CANADA on October 1st, 1986.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TRIACORT?
- What are the global sales for TRIACORT?
- What is Average Wholesale Price for TRIACORT?
Summary for TRIACORT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 4,809 |
| DailyMed Link: | TRIACORT at DailyMed |
US Patents and Regulatory Information for TRIACORT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solvay | TRIACORT | triamcinolone acetonide | CREAM;TOPICAL | 087113-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
